DrugDashboards

Market view

acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl

2 marketed package NDCs · 1 active manufacturer

Most dispensed: PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg; 325 mg; DEXTROMETHORPHAN HYDROBROMIDE 20 mg; 200 mg · Tablet · #100 tablets/bottle

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.9041 per unit over the past year.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.5$1.00May 2016Apr 202601companies actively selling

Latest · Apr 2026 — typical price $0.9041 · middle half $0.9041$0.9041 · full range $0.9041$0.9041 · 1 products · 1 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • DurafluSep 2, 2026
    Mfr exited
    Poly Pharmaceuticals, Inc. · acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl
  • DurafluAug 26, 2026
    Mfr entered
    Poly Pharmaceuticals, Inc. · acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl
  • DurafluJul 29, 2026
    Mfr exited
    Poly Pharmaceuticals, Inc. · acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl
  • DurafluJul 22, 2026
    Mfr entered
    Poly Pharmaceuticals, Inc. · acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl

Same drug class

Other molecules FDA puts in alpha-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl in shortage right now?
No. FDA does not currently list Acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl?
1 company has marketed Acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.